Platform Technologies Related to Oncology, Rare Genetic and Haematological Disease, and Medicinal Chemistry

Takeda Pharmaceutical are launching an open innovation initiative inviting researchers to submit their proposals addressing emerging technological platforms related to oncology, rare genetic or haematological disease, or medicinal chemistry. One‑year projects will be funded up to JPY 5,000,000 or equivalent amount, including indirect costs.

Projects should address one of four areas:

REF#6 Translational research platforms for immuno-oncology. Specifically: (i) translationally-relevant humanised animal models and/or in vitro/ex vivo tumour organoid systems...